Major histocompatibility complex (MHC)-mediated immune regulation of decidual leukocytes at the fetal-maternal interface
- PMID:20347157
- DOI: 10.1016/j.jri.2010.01.005
Major histocompatibility complex (MHC)-mediated immune regulation of decidual leukocytes at the fetal-maternal interface
Abstract
Self and non-self recognition is the key mechanism by which the immune system determines whether or not to mount an immune response. During pregnancy the maternal immune system must tolerate the persistence of non-self semi-allogeneic fetal cells in the maternal tissue. Although many mechanisms have been shown to contribute to the prevention of a destructive maternal immune response to fetal cells, the immune acceptance of the allogeneic fetus in pregnancy largely remains an immunological paradox (Billingham et al., 1953). The aim of this review is to describe the expression of the polymorphic histocompatibility antigens at the fetal-maternal interface, their interaction with maternal leukocytes and their possible roles in immune regulation at the fetal-maternal interface during human pregnancy.
Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.
Similar articles
- Fas ligand expression by maternal decidual cells is negatively correlated with the abundance of leukocytes present at the maternal-fetal interface.Qiu Q, Yang M, Tsang BK, Gruslin A.Qiu Q, et al.J Reprod Immunol. 2005 Apr;65(2):121-32. doi: 10.1016/j.jri.2005.01.007.J Reprod Immunol. 2005.PMID:15811517
- Maternal and fetal immune responses during pregnancy.Sargent IL.Sargent IL.Exp Clin Immunogenet. 1993;10(2):85-102.Exp Clin Immunogenet. 1993.PMID:8251183Review.
- The role of macrophages in utero-placental interactions during normal and pathological pregnancy.Renaud SJ, Graham CH.Renaud SJ, et al.Immunol Invest. 2008;37(5):535-64. doi: 10.1080/08820130802191375.Immunol Invest. 2008.PMID:18716937Review.
- HLA Class I protein expression in the human placenta.Blaschitz A, Hutter H, Dohr G.Blaschitz A, et al.Early Pregnancy (Cherry Hill). 2001 Jan;5(1):67-9.Early Pregnancy (Cherry Hill). 2001.PMID:11753519
- The maternal-fetal interaction: some controversies and solutions.Adinolfi M.Adinolfi M.Exp Clin Immunogenet. 1993;10(2):103-17.Exp Clin Immunogenet. 1993.PMID:8251179Review.
Cited by
- Major histocompatibility complex I mediates immunological tolerance of the trophoblast during pregnancy and may mediate rejection during parturition.Rapacz-Leonard A, Dąbrowska M, Janowski T.Rapacz-Leonard A, et al.Mediators Inflamm. 2014;2014:579279. doi: 10.1155/2014/579279. Epub 2014 Apr 9.Mediators Inflamm. 2014.PMID:24812442Free PMC article.Review.
- Evidence for a role for the adaptive immune response in human term parturition.Gomez-Lopez N, Vega-Sanchez R, Castillo-Castrejon M, Romero R, Cubeiro-Arreola K, Vadillo-Ortega F.Gomez-Lopez N, et al.Am J Reprod Immunol. 2013 Mar;69(3):212-30. doi: 10.1111/aji.12074. Epub 2013 Jan 24.Am J Reprod Immunol. 2013.PMID:23347265Free PMC article.
- Maternal leucocyte trajectory across pregnancy associated with offspring's growth.Chen H, Zhang Z, Zhou Y, Liu Y, Lin X, Wei Y, Sun R, Li L, Deng G.Chen H, et al.Pediatr Res. 2022 Sep;92(3):862-870. doi: 10.1038/s41390-021-01827-6. Epub 2021 Nov 8.Pediatr Res. 2022.PMID:34750526
- Thyroid autoantibodies in pregnancy: their role, regulation and clinical relevance.Balucan FS, Morshed SA, Davies TF.Balucan FS, et al.J Thyroid Res. 2013;2013:182472. doi: 10.1155/2013/182472. Epub 2013 Apr 18.J Thyroid Res. 2013.PMID:23691429Free PMC article.
- Immunological Changes in Pregnancy and Prospects of Therapeutic Pla-Xosomes in Adverse Pregnancy Outcomes.Devvanshi H, Kachhwaha R, Manhswita A, Bhatnagar S, Kshetrapal P.Devvanshi H, et al.Front Pharmacol. 2022 Apr 20;13:895254. doi: 10.3389/fphar.2022.895254. eCollection 2022.Front Pharmacol. 2022.PMID:35517798Free PMC article.Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials